Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial

Exp Clin Psychopharmacol. 2008 Apr;16(2):132-43. doi: 10.1037/1064-1297.16.2.132.

Abstract

The authors evaluated the efficacy of an interactive, computer-based behavioral therapy intervention, grounded in the community reinforcement approach (CRA) plus voucher-based contingency management model of behavior therapy. Our randomized, controlled trial was conducted at a university-based research clinic. Participants comprised 135 volunteer adult outpatients who met DSM-IV criteria for opioid dependence. All participants received maintenance treatment with buprenorphine and were randomly assigned to one of three treatments: (a) therapist-delivered CRA treatment with vouchers, (b) computer-assisted CRA treatment with vouchers, or (c) standard treatment. The therapist-delivered and computer-assisted CRA plus vouchers interventions produced comparable weeks of continuous opioid and cocaine abstinence (M = 7.98 and 7.78, respectively) and significantly greater weeks of abstinence than the standard intervention (M = 4.69; p < .05), yet participants in the computer-assisted CRA condition had over 80% of their intervention delivered by an interactive computer program. The comparable efficacy obtained with computer-assisted and therapist-delivered therapy may enable more widespread dissemination of the evidence-based CRA plus vouchers intervention in a manner that is cost-effective and ensures treatment fidelity.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Alcohols / blood
  • Alcohols / urine
  • Behavior Therapy / methods*
  • Buprenorphine / therapeutic use
  • Computer-Aided Design*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Narcotic Antagonists / therapeutic use
  • Opioid-Related Disorders / psychology
  • Opioid-Related Disorders / therapy*
  • Reinforcement, Psychology*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Alcohols
  • Narcotic Antagonists
  • Buprenorphine